Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]
Immunoglobulin Free Light Chains Kappa and Lambda Human ELISA | BioVendor R&D
For Myeloma Diagnosis, Urine Tests May Be Better Than Serum, Study Finds
KAPPA and LAMBDA assays, in serum and urine, for nephelometers and clinical chemistry analyzers - Clinical Laboratory int.
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
Artefactual bands on urine protein immunofixation gels
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Bence Jones protein - Wikipedia
SDS-PAGE gel analysis of purified urine light chains kappa and lambda.... | Download Scientific Diagram
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Viruses | Free Full-Text | Urine and Free Immunoglobulin Light Chains as Analytes for Serodiagnosis of Hantavirus Infection
Immunofixation - an overview | ScienceDirect Topics
A method to obtain purified free light chain monomers and dimers from urine samples of patients with multiple myeloma | Immunologic Research
American Journal of Hematology | Blood Research Journal | Wiley Online Library
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
PDF) Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With
Applying MASS-FIX to Urine Samples - Insights
Kappa / Lambda Urine Control
Kappa and Lambda Light Chains - HealthTree for Multiple Myeloma
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology